Literature DB >> 31737211

LINC01234 promotes multiple myeloma progression by regulating miR-124-3p/GRB2 axis.

Xueyan Chen1, Yin Liu2, Zihua Yang3, Jiang Zhang2, Shaoqian Chen2, Jing Cheng2.   

Abstract

LncRNA is gradually considered as a vital regulator in various physiological and pathological processes. Recently, the role of LINC01234 in several cancers has been reported. However, the function and underlying regulatory mechanism of LINC01234 in multiple myeloma (MM) remain unclear. Our results indicated that LINC01234 was over-expressed in tumor tissues of MM patients, and LINC01234 down-regulation remarkably inhibited cell proliferation, cycle progression and promoted cell apoptosis in MM cells. Mechanistic studies revealed that LINC01234 could sponge miR-124-3p and decreased its expression, thereby up-regulated the protein level of miR-124-3p's targets growth factor receptor-bound protein 2 (GRB2). Additionally, in vivo experiments revealed that LINC01234 shRNA could serve as a tumor suppressor through down-regulating GRB2 in MM. In this study, a novel established regulatory manner of LINC01234/miR-124-3p/GRB2 axis was systematically studied, which may hold promise as a promising target for MM treatment. AJTR
Copyright © 2019.

Entities:  

Keywords:  GRB2; LINC01234; Multiple myeloma; cell cycle; cell proliferation; miR-124-3p

Year:  2019        PMID: 31737211      PMCID: PMC6834521     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  38 in total

1.  MiR-433-3p Inhibits Proliferation and Invasion of Esophageal Squamous Cell Carcinoma by Targeting GRB2.

Authors:  Qizhong Shi; Yongling Wang; Yonghui Mu; Xin Wang; Qingxia Fan
Journal:  Cell Physiol Biochem       Date:  2018-04-28

2.  MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer.

Authors:  Wei Jiang; Ke Wei; Chunfeng Pan; Hong Li; Jing Cao; Xu Han; Yu Tang; Shichao Zhu; Weiwei Yuan; Yaozhou He; Yang Xia; Liang Chen; Yijiang Chen
Journal:  Cell Prolif       Date:  2018-08-02       Impact factor: 6.831

3.  Analysis of lncRNA-Protein Interactions by RNA-Protein Pull-Down Assays and RNA Immunoprecipitation (RIP).

Authors:  Holger Bierhoff
Journal:  Methods Mol Biol       Date:  2018

Review 4.  LncRNAs and miRNAs: potential biomarkers and therapeutic targets for prostate cancer.

Authors:  Guoxing Ma; Mingqing Tang; Yaqing Wu; Xiaoming Xu; Feng Pan; Ruian Xu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 5.  Multiple myeloma.

Authors:  Christoph Röllig; Stefan Knop; Martin Bornhäuser
Journal:  Lancet       Date:  2014-12-23       Impact factor: 79.321

Review 6.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

Authors:  Rajesha Rupaimoole; Frank J Slack
Journal:  Nat Rev Drug Discov       Date:  2017-02-17       Impact factor: 84.694

7.  From anecdote to targeted therapy: the curious case of thalidomide in multiple myeloma.

Authors:  Jonathan D Licht; Jake Shortt; Ricky Johnstone
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

8.  Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor.

Authors:  L Buday; J Downward
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

9.  Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesis.

Authors:  Bingzong Li; Hongxia Xu; Huiying Han; Sha Song; Xiaojuan Zhang; Lu Ouyang; Chen'ao Qian; Yating Hong; Yingchun Qiu; Wenqi Zhou; Moli Huang; Wenzhuo Zhuang
Journal:  Oncogene       Date:  2018-06-12       Impact factor: 9.867

10.  MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1.

Authors:  Ping Wang; Li Zhang; Junhui Zhang; Gangshu Xu
Journal:  Exp Ther Med       Date:  2017-11-17       Impact factor: 2.447

View more
  4 in total

1.  Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming.

Authors:  Muhua Chen; Chunfeng Zhang; Wei Liu; Xiaojuan Du; Xiaofeng Liu; Baocai Xing
Journal:  Mol Ther       Date:  2022-02-19       Impact factor: 12.910

2.  The LncRNA RP11-301G19.1/miR-582-5p/HMGB2 axis modulates the proliferation and apoptosis of multiple myeloma cancer cells via the PI3K/AKT signalling pathway.

Authors:  Faming Wang; Yao Luo; Le Zhang; Muhammad Younis; Liudi Yuan
Journal:  Cancer Gene Ther       Date:  2021-03-11       Impact factor: 5.987

3.  Tribbles homolog 3 contributes to high glucose-induced injury in retinal pigment epithelial cells via binding to growth factor receptor-bound 2.

Authors:  Qin Liao; Xuefeng Gao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

4.  Long Noncoding RNA LUCAT1 Promotes Multiple Myeloma Cell Growth by Regulating the TGF-β Signaling Pathway.

Authors:  Zhaoyu Liu; Hong Gao; Qing Peng; Yongheng Yang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.